Cargando…
Antibody-based cancer immunotherapy by targeting regulatory T cells
Regulatory T cells (Tregs) are among the most abundant suppressive cells, which infiltrate and accumulate in the tumor microenvironment, leading to tumor escape by inducing anergy and immunosuppression. Their presence has been correlated with tumor progression, invasiveness and metastasis. Targeting...
Autores principales: | Li, Quanxiao, Lu, Jun, Li, Jinyao, Zhang, Baohong, Wu, Yanling, Ying, Tianlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174253/ https://www.ncbi.nlm.nih.gov/pubmed/37182149 http://dx.doi.org/10.3389/fonc.2023.1157345 |
Ejemplares similares
-
Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
por: Nadeeshani, Harshani, et al.
Publicado: (2021) -
Combination of marine bioactive compounds and extracts for the prevention and treatment of chronic diseases
por: Ebrahimi, Belgheis, et al.
Publicado: (2023) -
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
por: Santich, Brian H., et al.
Publicado: (2020) -
IgG-like Bispecific Antibody CD3×EpCAM Generated by Split Intein Against Colorectal Cancer
por: Wang, Lei, et al.
Publicado: (2022) -
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
por: Wang, Lili, et al.
Publicado: (2019)